This document discusses how pharmacy impacts the patient experience through its many roles and interactions across the healthcare system. It touches on key areas like patient safety, medication safety, compliance, and proposed CMS changes. The document notes that pharmacy is involved in selecting, procuring, storing, dispensing, administering, and monitoring medications. It also discusses metrics around measuring medication errors and the case for improving sterile compounding practices.
TSDP tells about Post-marketing Drug-surveillance and their types. To know more about regulatory medical writing training, contact- hello@turacoz.in. know more, visit: http://turacozskilldevelopment.org/
Gone are the days of using spreadsheets to manage clinical trials. Fortunately, a clinical trial management system (CTMS) such as Oracle Siebel CTMS, offers an effective method for streamlining business processes, reducing cost and saving time.
Whether you are a sponsor running global trials or a research organization conducting hundreds of studies, Perficient’s Param Singh, Director of Clinical Trial Management Solutions, will teach you:
What a CTMS is and who needs one
Key functions of a CTMS
CTMS selection process
System types and implementation options
Best practices
TSDP tells about Post-marketing Drug-surveillance and their types. To know more about regulatory medical writing training, contact- hello@turacoz.in. know more, visit: http://turacozskilldevelopment.org/
Gone are the days of using spreadsheets to manage clinical trials. Fortunately, a clinical trial management system (CTMS) such as Oracle Siebel CTMS, offers an effective method for streamlining business processes, reducing cost and saving time.
Whether you are a sponsor running global trials or a research organization conducting hundreds of studies, Perficient’s Param Singh, Director of Clinical Trial Management Solutions, will teach you:
What a CTMS is and who needs one
Key functions of a CTMS
CTMS selection process
System types and implementation options
Best practices
Pharmacovigilanc: The science & activities relating to the Detection, Assessment, Understanding and Prevention of adverse effects or any other drug related problems
The Thalidomide Tragedy (Lessons for Drug Safety and Regulation)
CLASSIFICATION OF ADRS (RAWLIN AND THOMPSON CLASSIFICATION)
Why PV is Necessary?
Objective of PV
Outcomes of Drugs
Causal Relationship
Adverse drug reaction and causality assessment scales
Classification of AE
Serious Adverse Event (SAE)
Sources of Adverse Events (AE) reports
Sources of AE Reports(Solicited Reports)
What to Report?
Who to Report?
When to Report?
Individual case data flow
A structured approach to the investigation process should be used with the objective of determining the root cause.
The level of effort, formality, and documentation of the investigation should be commensurate with the level of risk, in line with ICH Q9.
> Patient engagement
> Patient advocacy groups
> Patient focused drug development
> Patient reported outcomes
> Patient centric clinical trials
> Patient preference studies
> Make patients as partners in research
> Institutionalised involvement - NICE, EMA, US-FDA
> Indian perspective
> Drivers for involving patients
An Introductory Presentation to Clinical Research. A go through from this presentation will give you a brief and clear introduction about Clinical Research.
FDA Regulations and Medical Device Pathways to MarketMethodSense, Inc.
Bringing your medical device to market requires in-depth attention to its safety, reliability and compliance. In addition to designing a quality medical device, it’s critical that you anticipate and address the requirements that allow you to introduce it to the market successfully.
Life Science consulting firm, MethodSense, discusses important FDA regulations as they relate to bringing a medical device to market, including 21 CFR Part 821, 510(k) approval and 21 CFR Part 11.
Pharmacovigilanc: The science & activities relating to the Detection, Assessment, Understanding and Prevention of adverse effects or any other drug related problems
The Thalidomide Tragedy (Lessons for Drug Safety and Regulation)
CLASSIFICATION OF ADRS (RAWLIN AND THOMPSON CLASSIFICATION)
Why PV is Necessary?
Objective of PV
Outcomes of Drugs
Causal Relationship
Adverse drug reaction and causality assessment scales
Classification of AE
Serious Adverse Event (SAE)
Sources of Adverse Events (AE) reports
Sources of AE Reports(Solicited Reports)
What to Report?
Who to Report?
When to Report?
Individual case data flow
A structured approach to the investigation process should be used with the objective of determining the root cause.
The level of effort, formality, and documentation of the investigation should be commensurate with the level of risk, in line with ICH Q9.
> Patient engagement
> Patient advocacy groups
> Patient focused drug development
> Patient reported outcomes
> Patient centric clinical trials
> Patient preference studies
> Make patients as partners in research
> Institutionalised involvement - NICE, EMA, US-FDA
> Indian perspective
> Drivers for involving patients
An Introductory Presentation to Clinical Research. A go through from this presentation will give you a brief and clear introduction about Clinical Research.
FDA Regulations and Medical Device Pathways to MarketMethodSense, Inc.
Bringing your medical device to market requires in-depth attention to its safety, reliability and compliance. In addition to designing a quality medical device, it’s critical that you anticipate and address the requirements that allow you to introduce it to the market successfully.
Life Science consulting firm, MethodSense, discusses important FDA regulations as they relate to bringing a medical device to market, including 21 CFR Part 821, 510(k) approval and 21 CFR Part 11.
How To Boost Hospital Performance By Optimizing Your PharmacyCompleteRx
Assessing and managing productivity is a complex process that takes the rights tools and people. While pharmacy may seem to be a small part of an overall organization, it is actually one of the largest cost centers of a hospital, making it one of the most important departments to optimize and streamline. Learn how your pharmacy’s productivity can impact your hospital’s overall costs, quality, safety and patient satisfaction.
Key Points:
- Analyzing productivity
- Pros and cons of pharmacy productivity management tools
- Use of volume indicators
- Workflows to improve productivity and communication with nursing and hospital staff
Learn insider tips from industry experts on how to successfully complete your URAC Specialty Pharmacy v3.0 accreditation requirements.*
You’ll walk away with insider knowledge about how to use tools, technology, and lessons learned that specialty pharmacies pay thousands of dollars to access.
describe about pharmaceutical marketing in digital era, how pharmaceutical industry development, hows the marketing and explain about promotional tools that use to develop the pharmaceutical marketing. this presentation also describe how research on sample use. direct to consumer (DTC) strategy, recomendation and distributuion models
How to achieve the NICE guidelines on Managing Medicines in Care HomesKarisBrummitt
The NICE Quality Standard on Managing Medicines in Care Homes is due for publication in March 2015. A NICE Quality Standard is a concise set of statements designed to drive and measure improvements in quality. They are based on national guidelines (including NICE guidelines which consist of around 90 recommendations) and can be used to review services, highlight areas where quality needs to be improved and offer suggestions as to how this can be achieved.
Rebecca M. Shanahan, CEO of Avella Specialty Pharmacy presents on Specialty Pharmacy at Retail Pharmacy at the 2014 Armada Summit. Learn more about Avella and connect with your local rep if you have any questions. http://www.avella.com/
Pain points - Overcoming the Opioid CrisisCompleteRx
Today, 11 percent of Americans experience daily chronic pain, for which opioids are frequently prescribed. Unfortunately, what started as standard prescribing practice has become detrimental, and due to their highly addictive nature, we’ve seen a quadrupling number of opioid overdose deaths from 1999 to 2015, killing more than 90 people per day. While state and national legislatures continue to search for ways to combat this epidemic, significant change can be made at the community level starting with medical staff, hospitals and health systems. This webinar will provide a comprehensive overview of the pain crisis and how it affects various patient populations, outline CDC guidelines on opioid use for chronic pain and identify strategies to positively impact the use of opioids and outcomes.
Sources: NCCIH, NPR
Key Takeaways:
- Recognize the relationship between opioid use on clinical and economic outcomes in various patient populations and the community
- Outline recommendations suggested by CDC guidelines on opioid use in chronic pain and new pain standards just released by TJC
- Identify strategies to impact multiple drivers of the opioid crisis
In today’s healthcare environment, there is an increasing emphasis on antimicrobial stewardship programs (ASP) and their impact on patient and community health and hospital financials. There are now new regulatory standards from The Joint Commission (TJC) that require hospitals to implement ASPs, and the Centers for Medicare and Medicaid Services (CMS) has proposed making it mandatory that hospitals implement an ASP in order to participate in Medicare and Medicaid. Regardless, a solid ASP is critically important to patient wellbeing, public health, and a hospital’s bottom line. This webinar will focus on how to bring a successful ASP to life in your hospital with a business plan and buy in from key stakeholders across the organization.
Eye on the Prize: Promoting a "Culture of Excellence" Through Effective Strat...CompleteRx
The epitome of excellence can be recognized in organizations that have been awarded the Malcolm Baldrige National Quality Award. The successful development and implementation of an organization’s strategic plan is pivotal to this achievement as it ensures leadership and employees are working toward common goals. While setting priorities and focusing resources may seem like a given for any successful organization, the process of establishing and measuring an effective strategic plan can be complex and overwhelming. In conjunction with the Kentucky Center for Performance Excellence (KyCPE), this webinar will teach you to develop a strategic planning process to improve your organization’s performance and ensure key performance indicators are aligned with your overall strategic plan. The webinar will also review past healthcare Malcolm Baldrige National Quality Award winners and share best practices from these award winners.
Key Takeaways:
- Understand strategy development and HOW do you develop your strategy
- Review what Baldrige winning organizations have done to develop information for your strategic planning process
- Learn how to deploy your action plans
5 Ways Your Pharmacy Can Boost Your Revenue CycleCompleteRx
With rising drug costs and decreasing reimbursements contributing to shrinking margins (in 2014, according to Modern Healthcare, 61.3 percent of healthcare providers reported decreased margins from the previous year), hospitals continue to scrutinize their revenue cycles to ensure they stay in the black, and there’s an oft-overlooked resource they would do well to consider: pharmacy. Historically, the hospital pharmacy has been labeled a cost generator, but there are actually many ways this strategic department can positively impact each stage of the revenue cycle – from point of service to claim submission and more. This webinar will explore innovative tactics, including optimized processes, improved data management, and creative patient programs, which hospital pharmacies across the country can leverage to boost overall hospital revenue.
The Cure for a Healthy Recruitment and Retention StrategyCompleteRx
Losing a qualified job candidate or employee can be a tough pill to swallow. No matter what the position, finding job candidates that are the right fit are hard to come by in the ever-changing healthcare market. A recent McKinsey & Co study suggests there could be an 18 million-person shortage in the supply of high-skilled, college-educated workers by 2020 – this includes pharmacy and healthcare workers. On top of that, workforce demographics, technology and benefits continue to evolve as the new millennial workforce sets expectations for what they want in a career. In this webinar, you’ll hear from our talent acquisition and pharmacy operations teams as they strategize new ways to recruit and retain top talent today.
How High Will They Go? Managing Rising Drug Prices in a Changing Healthcare E...CompleteRx
In 2016, spending on prescription drugs is expected to reach $500 billion. So, how high will they really go? That is a common question asked with drug prices as recent headlines have exploited drug pricing schemes and how the pharmaceutical industry is handling rising prices. This webinar discusses how hospitals and health systems can prepare for and manage rising drug costs, ensure patient care and positively impact the bottom line.
The Rise (or Fall?) of Pharmacy Management in the Technology AgeCompleteRx
Technology is a critical tool in providing quality, cost
effective healthcare. An overview of key technologies
which effect day to day pharmacy management will be
reviewed. Future market and technology trends which
could alter the professional landscape for pharmacy will
be discussed.
Five Pharmacy Rules Hospitals Can't Afford To Ignore In 2016CompleteRx
With each new year comes increased regulations that affect the hospital ecosystem. This webinar will take a look at the approved and proposed regulatory requirements for hospital pharmacies that have been published to be proactive and ensure compliance.
The 340B Program and Implications of the Mega GuidanceCompleteRx
As the 340B Drug Pricing Program continues to undergo changes, our team has been following all the recent updates and how they impact hospital pharmacies. This presentation goes through the latest on the long awaited guidance of proposed changes that was posted by the Federal Register on August 28, 2015.
Criteria for Performance Excellence to Improve Pharmacy ServicesCompleteRx
- Enhance understanding of the Performance Excellence program and the impact on Healthcare organizations
- Be able to locate Process level and Results level items and how to begin
- Identify areas in the hospital pharmacy that can be impacted by the program
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
3. Today's Objectives
1. How pharmacy impacts the patient experience
2. Key patient safety and pharmacy compliance
techniques
3. Evidence for creating a medication safety program
4. Impact of CMS proposed changes
5. Evolving Healthcare Delivery System
Past
• Treating sickness
• Inpatient care
• Silos
• Fee per service
• Dispensing
Current
• Wellness
• Ambulatory care
• Integrated Team
• Value
• ?
15. There are approximately
7,000 deaths annually
associated with medication
errors.
If two out of 100 admissions
have a medication error, the
cost to the system is
$2 billion annually.
18. CMS Conditions of Participation
The regulations at §482.23(c) and §482.23(c)(1) promote
safety in the preparation and administration of drugs and
biologicals to hospital patients by requiring preparation
and administration in accordance with:
Federal and State law
Accepted standards of practice
(Rev. 137, 04-01-15)
20. Poll Question
How confident are you that your
medication error reporting system is
capturing all reportable events?
21. How Good Are We Measuring?
Voluntary Reporting System
Reported Events
50 per Month
Observation and Chart Review
Single Unit (CCU)
0.86 errors per Patient Day
28
Average number
of errors per day
22. How Good Are We Measuring?
54321
100
80
60
40
20
Appraiser
Percent
95.0% C I
Percent
54321
100
80
60
40
20
Appraiser
Percent
95.0% C I
Percent
Date of study: April 2010
Reported by:
Name of product: Physician Order Review
Misc:
Assessment Agreement
Within Appraisers Appraiser vs Standard
23. Procure/
Store
Preparing and
Dispensing
Inputs Outputs
Select/
Prescribe
Administration
Suppliers Customer
Ordering and
Transcribing
Monitoring and
Evaluation
Medication
Management
Process
• Patient
• GPO
• Wholesaler
• Direct
Purchase
• Medical Staff
• Medications
• Disease State
• Drug
Information
• Contract
Pricing
• Five Rights
• Regulatory
documentation
• QA
Information
• Patient
• Medical Staff
• Regulatory
Agency
Taxonomy of Medication ErrorsTaxonomy of Medication Errors
24. Risk Mitigation Strategy
Selection &
Procurement Process Storage
Medication
Name/Class
Select medications based on the
dependability and reliability of the
manufacturer
Physically separate look-alike/sound-alike
medications
Address the potential for adverse
medication events when
medications are frequently changed
Build in system alerts and use warning
labels regarding problematic drug names,
packaging, and labeling
Consider whether product is labeled
correctly
Consider labeling medications with both
the generic and brand name
Develop policies and processes for
handling drug outages
Handle boxes that contain chemotherapy
agents with chemotherapy-protective
gloves; store in negative pressure room
Develop policies and procedures for
inspecting all storage areas
25. At-Risk Identification
Performance Criteria
Assessment
Behavior Identified
Patient Information
A. Preparing more than one patient’s medications/more than one
medication at one time
B. Not checking patient identification using two identifiers (e.g.,
name, medical record number, birth date)
C. Using an estimated patient weight compared to an actual weight
D. Prescribing/dispensing/administering medications without
checking patients’ laboratory values and vital signs
E. Not checking a patient’s allergies before
prescribing/dispensing/administering medications
F. Not waking the patient for assessments/medications
G. Not viewing/checking the patient’s complete medication profile
(or medication administration record [MAR]) prior to
prescribing/dispensing/administering medications
[RICK]
Imagine you have a child that is critically ill with a high fever and your doctor tells you “Get them to the emergency room right away” so off you go to the emergency room where the attending physician writes for an antibiotic and then you wait for almost 20 hours to get the antibiotic.
Or imagine that your grandfather needs to go to the hospital because his diabetes is out of control. He’s stabilized, started on a new drug and discharged. But than grandpa goes home and to starts complaining of heart palpitations, and his legs start to swell. He’s readmitted three weeks later and after three days of tests is told his symptoms were the side effect of a new drug he was started on at discharge. A side effect he was never told about when he was discharged and which wasn’t included on his readmission medication reconciliation history.
Or imagine that your doctor tells you that you have just been diagnosed with an aggressive form of cancer. She tells you to make arrangements to start chemotherapy right away. You set up your appointment, go to the center to start your treatment, and are told that the drug you need is on back-order and you’ll need to come back in three days.
Can you imagine how these patients must have felt? Or their families? Can you imagine how you would feel hearing about these stories at your team meetings? I can, because they are all real.
During our time together I’m going to try and help you better understand how pharmacy can play a larger role to improve the patient care experience at your hospital.
First; We are going to make the case that the current view many hospitals have of their pharmacy department is too narrow and must change in order for hospitals to succeed in today’s value driven market;
Second; My colleague Ken Maxik is going to provide insights on how medication safety plays a significant role in the patient experience and provide some pointers on how to improve programs at your facilities.
Third; We will discuss the data around medication safety programs and the impact on patient experience results
And finally, the impact of proposed CMS changes regarding medication safety.
[BECKERS TO LAUNCH POLL QUESTION]
Before we get started I’d like to run a brief poll to better understand who has administrative oversight for pharmacy services at your facility. So if you could, please take a few seconds to answer the following poll question.
Which best describes who Pharmacy reports to at your facility?
COO
CNO
VP of Ancillary/Clinical Services
Other Hospital Executive
Does not apply
[RICK]
As you know, health care is in the midst of a big paradigm shift.
Under the old paradigm hospitals focused primarily on treating sickness with most care being delivered in an inpatient setting with reimbursement provided based on a fee per service model.
Currently the emphasis is on looking at the total health of the patient with heavy emphasis on patient education and wellness as a means to try and keep patients health and out of the hospital. Quality of care is also emphasized and those that deliver on quality will be rewarded through higher payments via value based purchasing incentives.
So what does this all have to do with pharmacy? For many organizations the primary view of pharmacy is focused on supply chain. Orders come down to the pharmacy and the medications are dispensed but I’d like to challenge that thought process..
[RICK]
Pharmacy is a link in something much bigger called the medication use cycle. For our pharmacists in the audience this diagram is very familiar. But I’d like to take some time and to make the case to show how complex the process can be and all the players that are involved.
[RICK]
Of course a key role of a pharmacy is to dispense drugs. And to run the pharmacy itself you needed to work with HR to hire people, finance to pay them and buy drugs, and IT to make the computer systems work. But it doesn’t stop there.
Unfortunately, many hospital leaders feel this is the primary role of pharmacy. This is why many institutions erroneously measure pharmacy productivity only by doses dispensed or orders processed. But as we will see pharmacy has a bigger role that touches many departments.
[RICK]
After the drug is dispensed it needs to get to the patient. This means you need to have in place multiple supply chain delivery systems to get new drugs up when they are needed and take the old drugs back for processing.
Most in are audience are familiar with the processes. But in addition to the above, you also have to make sure SMART pumps dictionaries are up to date, that par levels are set appropriately in your dispensing cabinets and that the drug information in the bar code data base can be read by the bar code reader. And pharmacy is a part of that.
[RICK]
And once the patient gives the drug the patient needs to be monitored. That means managing pharmacokinetic dosing protocols and working with microbiology to make sure you have the panels that match with your antibiotic formulary. Pharmacy also has to work with nursing to provide information and education about new drugs and the adverse effects. And pharmacy is a part of that.
[RICK]
As health care providers we want to make sure that patients are having good outcomes and that drugs are being prescribed in the most safe, cost-effective manner. This means conducting medication use evaluations, establishing adverse drug reaction surveillance programs, managing medication error reporting systems, and performing root cause analysis and failure mode effects analysis to keep patients safe and improve quality. And pharmacy has a part in that.
[RICK]
All this is going on why trying to figure out where you’re going to get your drugs when everything seems to be short or on back-order and then making sure everything is stored under proper conditions with the proper level of security all why staying in budget. And pharmacy is a part of that.
[RICK]
And in order to know what drugs to dispense, administer, monitor, and order the medical staff have to approve a formulary and all the medication protocols. They also need to have input into the order sets used for CPOE. Which means pharmacy needs to research literature and conduct pharmaco-economic analysis so the medical staff can make well informed decisions. And pharmacy is a part of that.
[RICK]
Now for the most part the patient doesn’t see all this. To them it is invisible until the time they receive their medication. But the process is extremely important when you think about the impact the medication use cycle has on your patients’ care. Think about this:
The medication use cycle will touch just about every patient that walks into the hospital.
I’ll say it again: The medication use cycle will touch just about every patient that walks into the hospital.
Not everybody gets an x-ray, or physical therapy, or has a surgical procedure, but almost every patient will receive a medication. And in order for the patient to have the best experience from their drug therapy this process must be carried out flawlessly with thousands of transactions occurring each day. And the lynch pin that is at the center of this complex cycle is pharmacy.
So as you think about your pharmacy, don’t think about it as a room in basement that fills orders, makes IVs, and does a few pharmacokinetic consults. Think of pharmacy services as a type of clinical treatment center, for example your Drug Therapy Services, similar to how you would view Interventional Cardiology, Surgery, or Oncology Services.
So now let’s shift gears and walk in the patient’s shoes and see how pharmacy can impact their experience.
14
[KEN]
So what is or can be the impact on patient care of not only the pharmacy, but the medication management system in general, and we have come a long way, but most remember we are on a journey. What we are going to review is some background of what brought us to where we are today, and some thoughts on moving forward.
On November 29, 1999 the Institute of Medicine released a report called To Err is Human. The authors concluded that more people die every year from medical errors than motor vehicle accidents, breast cancer, or AIDS, and when you extrapolate the results from this reports and others the numbers came out between 44,000 and 98,000 deaths due to medical errors.
When we review the sub-category of medication errors, there are approximately 7,000 deaths annually associated with medication errors; both in and outside the hospital. In an additional study, it was notes that two out of 100 admissions have a adverse drug event, the cost to the system is $2 billion annually.
[KEN]
As we mentioned previously we had the cases related to Heparin excess doses in 2006 and 2007, and as we have seen when these type of events occur, they usually hit the local and in some cases the national news media. And, unfortunately, these type of cases continue to occur in today’s healthcare systems. Some more recent cases have involved a mix up between high alert medications and other relate to errors associated with look- alike sound – alike medications.
[KEN]
And the next area that has been receiving attention both within the industry and the news media are events related to sterile compounding. This type of event was highlighted based upon sterility of products coming from the New England Compounding Center.
This event brought about a regulatory change through the Food and Drug Administration and the creation of a 503b compounding facility.
It does make you pause and consider why is it that as an industry such a tragic patient events are needed to move us to improve the quality of the services provided.
[KEN]
And these events also brought about a regulatory change related to the Center for Medicare and Medicaid Services in the definition of Accepted Standards of Practice
Hospital policies and procedures for the preparation and administration of all drugs and biologicals must not only comply with all applicable Federal and State laws, but also must be consistent with accepted standards of practice based on guidelines or recommendations issued by nationally recognized organizations with expertise in medication preparation and administration. Examples of such organizations include, but are not limited to, and here in the definition they include:
• National Coordinating Council for Medication Error Reporting and Prevention (www.nccmerp.org);
• Institute for Healthcare Improvement (http://www.ihi.org/ihi) ;
• U.S Pharmacopeia (www.usp.org) ;
• Institute for Safe Medication Practices (www.ismp.org );
Among others.
And as of January this definition also includes Critical Access Hospital: Interpretive Guidelines §485.635(a)(3)(iv)
[KEN]
So how do we move the needle and what type of results can we expect. We are all aware of high reliability industries, and those that are frequently referenced are the airline and nuclear power industries, but what is a high reliability organization, what type of results can be expected and what are some steps to move in that direction?
First within a high reliability organization, Everyone who works in these organizations, both individually and together, is acutely aware that even small failures in safety protocols or processes can lead to catastrophic adverse outcomes. Workers in these organizations are always searching for the smallest indication that the environment or a key safety process has changed in some way that might lead to failure, if some action is not taken to solve the problem.
Chassin, M, Loeb, M: The Ongoing Quality Improvement Journey: Next Stop, High Reliability Health Affairs on June 1, 2011
There was a study published ASQ – in the Quality Management Journal (QMJ) July 2015. This study compared 34 U.S. health care organizations that received the Baldrige National Quality Award or was eligible for a site visit, with 153 geographically closest competitors. The conclusion was that the Baldrige Award recipients matched or exceeded their competitors’ measures of health care quality and outperformed them in measures of favorable patient experience.
When you examine the resulting data for 39 measures that U.S. hospitals publicly report to the Centers for Medicare and Medicaid Services, Hospitals that used the Baldrige Health Care Criteria for Performance Excellence had higher means and lower standard deviations, indicating a measurable positive patient experience, than the non-Baldrige hospitals in all 10 measures.
We will cover in a minute, what are some ways we can move in this direction. But first, let me ask you a question?
[KEN]
[BECKERS TO LAUNCH POLL QUESTION]
How confident are you that your medication error reporting system is capturing all reportable events?
Highly Confident
Confident
Somewhat Confident
Not Confident
[KEN]
So, if the old adage of what gets measured gets done is taken into consideration. Then we have to ask ourselves as healthcare workers How Good Are We Measuring the Adverse Medication information data? Most of us today utilize a voluntary reporting system for capturing data, and are aware of the flaws with such a system. However, we wanted to know what sort of variance this creates, so we looked at one facility with a census of around 350, and they were reporting 50 events per month. We then conducted a prospective review for events on a single unit, and determined a error rate of 0.86 errors per patient day. This translated into a error rate of 28 events per day on just one unit.
This meant that every patient on that unit was involved in a medication event.
[KEN]
In another review we looked at pharmacists as our first line of defense in protecting patients from receiving a medication error. So, we asked them to review physician orders; both paper and electronic, and determine if the order was incomplete.
In this Attribute System Analysis that was conducted over two weeks timeframe, we noted that the pharmacist; Appraiser in the graph, was good at being consistent with themselves, but not good consistency between the five reviewers.
And, when we compared the reviewers with what we had predefined as the correct answer, there was a poor correlation. This brought us to the conclusion that if we wanted to improve the process we first needed to look at improvements in the front end of the process. Training for individuals would need to be conducted along with a rewrite and review of the policy and procedure to allow for a standardized approach to the definition used in determining if a written order is complete.
So while we have great intentions, we still need to do a better job.
[KEN]
When looking at an event we want to review all of the areas of the process, and many of you will recognize this as a SIPOC diagram, starting with the Suppliers to the process, which could be the wholesaler or medical staff – next we review the system inputs which are the items that need to go through the process in order to turn the inputs into the desired output. The Medication Management Process has bee broken down into the six steps that are listed here going from Selection and Procurement to Monitoring and Evaluation. And by following this process we will create an output that the customer needs and is willing to pay for. In our case it may also be payment by a third party.
We can look and determine that one of the first risk mitigation strategies is around the formulary system; selection and procurement. After all, it is more difficult to make a medication error if the medication is not on the formulary, your shelf, or in the computer system. Each of the sub-process steps will contain multiple risk mitigation strategies. Let’s look at a sample based upon high alert medications.
[KEN]
I know this slide is difficult to read, however, I just wanted to provide a brief overview of how an organization can set up a Risk Mitigation Strategy tool. Along the first column is placed either the medication name or medication class that your organization has decided will be treated as a High Alert Medication. Then across the top lines are various strategies that can be used in order to reduce risk at a specific point in the process. For example, Selection and Procurement.
What I find frequently when going to organizations is that the same strategy is used for all medications. For example if we had a medication event, then we add a second check. As we noted in the SIPOC diagram on the other slide, let’s looks at the entire medication management system and determine where we can put mitigation strategies into place.
[KEN]
Another mechanism that is available to assist in moving an organization toward high reliability is utilizing current staff members to aid in identifying at risk behavior.
At – risk behavior is when people deviate from accepted process safe standards, and they usually do this in order to save time, or because of the need to have a work around.
An example of engaging in at risk behavior would be if you are driving a car and sending a text message. Now we all know that this is a habit that we should not do. However, we also know that we have done this on numerous occasions and have not had any negative consequences of our actions, and this is the issue surrounding at risk behavior. There is a separation frequently in time from engaging in the behavior, and the time an event occurs.
So we put together a simple form for staff to use in order to identify at risk behavior, it does not take long, and is fashioned after the LEAN philosophy of Gemba, for those of you who are working in Lean organization. We ask each staff member to spend two hours per year observing the work getting done, and identify at risk behavior in the workplace.
This information is collected and then can be reported back to staff during meetings or huddles.
[KEN]
As was noted previously sterile compounding could be an entire webinar on its own. So, for today, let’s look at some high level areas. First, who do we allow to compound, how have we trained them and identified their competency? Are they working in an environment that causes them to be compliant with requirements?
At one facility I was at they had received a report from their third party contractor and placed it into the filing cabinet. When I asked to look at the report, the room had not passed the environmental testing, and had listed the colony forming units on the report.
Review your documentation and implement preventive and corrective action as needed.
I hope that we can see the impact that medication safety has on the patient experience, but also how moving to a high reliability organization, will improve the patient experience and financial impact for the organization. And with this I will hand it back to Rick.
[RICK]
The skills needed to run pharmacy are becoming more a more complex.
As an early careerist, the focus of pharmacy management was primarily on managing the staff, dispensing medications, and conducting a few quality improvement activities to satisfy Joint Commission. Today’s environment is much more complex.
The ability to understand and manage technology continues to increase. There is actually now a subspecialty of pharmacy called pharmacy informatics and my old Alma matter the University of Illinois now offers a Masters in this discipline.
Regulatory requirements are another area to consider. I serve as the Director of Professional and Legal affairs for the Gulf Coast Society of Pharmacists. At a recent conference I learned that pharmacy is now the most regulated profession out of all the health disciplines. The regulations that effect pharmacy are many and are continuously changing from federal requirements, state laws, USP 797/800, 340B, and on and on not to mention all the compliance standards for accreditation agencies. Recently the Drug Supply Chain Security Act went into effect.
In addition drug therapies will become more complex. Biosimilars are just hitting the market and pharmaco-genomic therapies will not be far behind. When I hear about the complexities of these drugs I long for the days of arguing which H2 antagonist was the best one to have on formulary.
Now finding a director with all these skill sets is becoming increasingly difficult. Most people either know a little about a lot or a great deal about one area. And finding a director willing to take a leadership role is difficult and will become more difficult especially as the current generation of pharmacy directors retire. This is because generation x and millennials for the most part do not want the leader chair opting for jobs which offer a better work life balance.
The point I’m trying to make with this slide is that pharmacy is very complex. And in order to deliver for the patients hospitals need to make the proper investments in people, technology, and infrastructure to make sure the patient has a safe, positive experience during their treatment keeping in mind that not all the results will impact the pharmacy P&L directly.
[RICK]
So from our brief time I hope that 1) you will make the paradigm shift away from thinking of pharmacy as dispensing drugs and instead view pharmacy as a key player in the patients treatment 2) that you have a better understanding of how pharmacy can impact the patient experience and that 3) pharmacy is getting more complex and having the right skill sets and leadership are key and see that pharmacy can have a financial ROI which extends beyond the pharmacy financial statement.
Before I close out I’d like you to take some time to reflect on the talking points. Now take out a piece of paper and rate your hospital as it relates to pharmacy’s role in the patients experience and rate it as excellent, average, poor, or perhaps I really don’t know or haven’t thought about it.
If you answered excellent, congratulations. But if you answered average, poor or even I haven’t thought about it, make it a point to talk to have a discussion about what can be done to get the best most out of your investment in pharmacy resources to give your patients the best experience possible.